Showing results (521-530 of 586) with videos related to
Sort By:
Pageof 59
European Heart Journal|September 12, 2014
Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF TrialBenjamin A Steinberg, Anne S Hellkamp, Yuliya Lokhnygina, et al.American Heart Journal|July 29, 2014
Prevalence, characteristics, and predictors of early termination of cardiovascular clinical trials due to low recruitment: insights from the ClinicalTrials.gov registrySabrina Bernardez-Pereira, Renato D Lopes, Maria Julia Machline Carrion, et al.Journal of the American College of Cardiology|February 9, 2013
Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)Manesh R Patel, Anne S Hellkamp, Yuliya Lokhnygina, et al.Stroke|April 19, 2014
Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillationGraeme J Hankey, Susanna R Stevens, Jonathan P Piccini, et al.Journal of the American Heart Association|March 10, 2016
Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AFSean D Pokorney, Jonathan P Piccini, Susanna R Stevens, et al.JAMA|August 10, 2002
Sertraline treatment of major depression in patients with acute MI or unstable anginaAlexander H Glassman, Christopher M O'Connor, Robert M Califf, et al.JAMA|August 27, 2009
Sex differences in mortality following acute coronary syndromesJeffrey S Berger, Laine Elliott, Dianne Gallup, et al.Journal of Cardiac Failure|February 18, 2014
High-sensitivity C-reactive protein in acute heart failure: insights from the ASCEND-HF trialAndreas P Kalogeropoulos, W H Wilson Tang, Amy Hsu, et al.American Heart Journal|May 3, 2005
Conducting economic evaluations alongside multinational clinical trials: toward a research consensusShelby D Reed, Kevin J Anstrom, Ameet Bakhai, et al.Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Systematic adjudication of myocardial infarction end-points in an international clinical trialKenneth W Mahaffey, Robert A Harrington, Martijn Akkerhuis, et al.Pageof 59